Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells

od Sloss, Callum M., Wang, Fang, Palladino, Michael A., Cusack, James C.
Izdano 2010

Effects of lipopolysaccharide-induced inflammation on hypoxia and inflammatory gene expression pathways of the rat testis

od Palladino, Michael A., Fasano, Genevieve A., Patel, Dharm, Dugan, Christine, London, Marie
Izdano u Basic Clin Androl (2018)

Myeloid cell leukemia-1 (Mc1-1) is a candidate target gene of hypoxia-inducible factor-1 (HIF-1) in the testis

od Palladino, Michael A, Shah, Anoop, Tyson, Rebecca, Horvath, Jaclyn, Dugan, Christine, Karpodinis, Marie
Izdano 2012

Discovery and Development of the Anticancer Agent Salinosporamide A (NPI-0052)

od Fenical, William, Jensen, Paul R., Palladino, Michael A., Lam, Kin S., Lloyd, G. Kenneth, Potts, Barbara C.
Izdano 2008

Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma

od Chauhan, Dharminder, Singh, Ajita V., Ciccarelli, Bryan, Richardson, Paul G., Palladino, Michael A., Anderson, Kenneth C.
Izdano 2010

Pharmacodynamic and Efficacy Studies of the Novel Proteasome Inhibitor NPI-0052 (marizomib) in a Human Plasmacytoma Xenograft Murine Model

od Singh, Ajita V., Palladino, Michael A., Lloyd, G. Kenneth, Potts, Barbara, Chauhan, Dharminder, Anderson, Kenneth C.
Izdano u Br J Haematol (2010)

A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells

od Singh, Ajita V., Bandi, Madhavi, Raje, Noopur, Richardson, Paul, Palladino, Michael A., Chauhan, Dharminder, Anderson, Kenneth C.
Izdano 2011

Proteasome inhibition activates EGFR and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells: Implications for combination therapy

od Sloss, Callum M., Wang, Fang, Liu, Rong, Xia, Lijun, Houston, Michael, Ljungman, David, Palladino, Michael A., Cusack, James C.
Izdano 2008

Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma

od Chauhan, Dharminder, Singh, Ajita, Brahmandam, Mohan, Podar, Klaus, Hideshima, Teru, Richardson, Paul, Munshi, Nikhil, Palladino, Michael A., Anderson, Kenneth C.
Izdano 2008

Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB–regulated gene products

od Ahn, Kwang Seok, Sethi, Gautam, Chao, Ta-Hsiang, Neuteboom, Saskia T. C., Chaturvedi, Madan M., Palladino, Michael A., Younes, Anas, Aggarwal, Bharat B.
Izdano 2007

Proteasome Inhibitors Prevent Caspase-1-Mediated Disease in Rodents Challenged with Anthrax Lethal Toxin

od Muehlbauer, Stefan M., Lima, Heriberto, Goldman, David L., Jacobson, Lee S., Rivera, Johanna, Goldberg, Michael F., Palladino, Michael A., Casadevall, Arturo, Brojatsch, Jürgen
Izdano 2010

Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs

od Miller, Claudia P., Manton, Christa, Hale, Randal, DeBose, LaKeisha, Macherla, Venkat R., Potts, Barbara C., Palladino, Michael A, Chandra, Joya
Izdano 2011

Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs

od Obaidat, Amanda, Weiss, Jeffrey, Wahlgren, Brett, Manam, Rama R., Macherla, Venkat R., McArthur, Katherine, Chao, Ta-Hsiang, Palladino, Michael A., Lloyd, G. Kenneth, Potts, Barbara C., Enna, Salvatore J., Neuteboom, Saskia T. C., Hagenbuch, Bruno
Izdano 2011

Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemia

od Roccaro, Aldo M., Leleu, Xavier, Sacco, Antonio, Jia, Xiaoying, Melhem, Molly, Moreau, Anne-Sophie, Ngo, Hai T., Runnels, Judith, Azab, Abdelkareem, Azab, Feda, Burwick, Nicholas, Farag, Mena, Treon, Steven P., Palladino, Michael A., Hideshima, Teru, Chauhan, Dharminder, Anderson, Kenneth C., Ghobrial, Irene M.
Izdano 2008